Daulong, Markclent .
HRN: 23-00-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/03/2025
02/10/2025
IV
350mg
Q6h
Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes